Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    A
  • Apixaban

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formCrystalline form N-1

    CAS No.503612-47-3

    View more
  • R
  • Rivaroxaban

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formModification I

    CAS No.366789-02-8

    View more
  • T
  • Ticagrelor

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formForm II

    CAS No.274693-27-5

    View more